Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Using soluble urokinase plasminogen activator receptor to stratify patients for medication review in the emergency department

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Obesity-induced CYP2E1 activity in children

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Higher chlorzoxazone clearance in obese children compared with nonobese peers

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Development of one paediatric and one neonatal formulary list in hospital settings

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  • Anne Kathrine Bengaard
  • Esben Iversen
  • Thomas Kallemose
  • Helle Gybel Juul-Larsen
  • Line Jee Hartmann Rasmussen
  • Kim Peder Dalhoff
  • Ove Andersen
  • Jesper Eugen-Olsen
  • Morten Baltzer Houlind
Vis graf over relationer

AIMS: To investigate whether the association between levels of medication use (including polypharmacy and potentially inappropriate medications [PIMs]) and health outcomes such as readmission and mortality is dependent on baseline soluble urokinase plasminogen activator receptor (suPAR).

METHODS: This registry-based cohort study included medical patients admitted to the emergency department at Copenhagen University Hospital Hvidovre, Denmark. Patients were grouped according to their admission suPAR levels: low (0-3 ng/mL), intermediate (3-6 ng/mL), or high (>6 ng/mL). Hyper-polypharmacy was defined as ≥10 prescribed medications. PIMs were identified based on the EU(7)-PIM list, and data on admissions and mortality were obtained from national registries. Risk of 90-day readmission and mortality was assessed by Cox regression analysis adjusted for sex, age and Charlson comorbidity index. Results were reported as hazard ratios within 90 days of index discharge.

RESULTS: In total, 26 291 patients (median age 57.3 y; 52.7% female) were included. Risk of 90-day readmission and mortality increased significantly for patients with higher suPAR or higher number of medications. Among patients with low suPAR, patients with ≥10 prescribed medications had a hazard ratio of 2.41 (95% confidence interval = 2.09-2.78) for 90-day readmission and 8.46 (95% confidence interval = 2.53-28.28) for 90-day mortality compared to patients with 0 medications. Patients with high suPAR generally had high risk of readmission and mortality, and the impact of medication use was less pronounced in this group. Similar, but weaker, association patterns were observed between suPAR and PIMs.

CONCLUSION: The association between levels of medication use and health outcomes is dependent on baseline suPAR.

OriginalsprogEngelsk
Artikelnummer14982
TidsskriftBritish Journal of Clinical Pharmacology
Vol/bind88
Udgave nummer4
Sider (fra-til)1679-1690
Antal sider12
ISSN0306-5251
DOI
StatusUdgivet - apr. 2022

ID: 66725211